Potential public health impacts of gonorrhea vaccination programmes under declining incidences: A modeling study
Vaccination of MSM against gonorrhea, according to risk in sexual health clinics in Singapore, can be considered to reduce gonorrhea acquisition and transmission. Development of gonorrhea-specific vaccines which focuses on protective efficacy and the implementation of efficient vaccination programmes can maximize public health impact.
Authors
- Lilith K. Whittles (ORCID: https://orcid.org/0000-0002-8913-0391)
- Borame Sue Lee Dickens (ORCID: https://orcid.org/0000-0003-1592-1745)
- Azra C. Ghani (ORCID: https://orcid.org/0000-0002-0007-4910)
- Rayner Kay Jin Tan (ORCID: https://orcid.org/0000-0002-9188-3368)
- Y Chen (ORCID: https://orcid.org/0009-0000-4787-0378)
- Martin Tze‐Wei Chio (ORCID: https://orcid.org/0000-0001-5440-6688)
- Jue Tao Lim (ORCID: https://orcid.org/0000-0002-2245-0331)
- Lin Geng
Institutions
- National Skin Centre (SG)
- National University of Singapore (SG)
- Nanyang Technological University (SG)
- National University Health System (SG)
- Imperial College London (GB)
Publication Details
- Journal
- PLoS Medicine
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1371/journal.pmed.1004521
- Citations
- 3
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 3.55
Funders
- Imperial College London
- Nanyang Technological University